Beta Drugs Limited — Important, 05-05-2025: Updates

Beta Drugs has secured COFEPRIS approval for its oncology formulation plant in Baddi and API facility in Derabassi, enabling entry into Mexico’s $1.3 billion oncology market. This enhances API export capabilities, improving margins and supply chain control by cutting dependence on third-party suppliers. Facility upgrades and planned EU audits position Beta to expand into other PICs nations and tap into the fast-growing global oncology sector, supporting export-driven growth.